In view of the above limitations, the findings presented here should be considered as preliminary; additional investigations focusing on gene-to-gene or gene-to-environment interactions and seeking to elucidate the molecular mechanisms whereby genetic variation in the TPH-2 gene and other candidate genes are involved in the pathogenesis of insomnia and depression are needed in the future. Here, TPH2 is linked to depressive symptom measurement.